The efficacy and safety of a nicotine conjugate vaccine (NicVAX (R)) or placebo co-administered with varenicline (Champix (R)) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial

Philippe H. J. Hoogsteder, Daniel Kotz, Paul I. van Spiegel, Wolfgang Viechtbauer, Ruth Brauer, Paul D. Kessler, Matthew W. Kalnik, Raafat E. F. Fahim, Onno C. P. van Schayck

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1052
JournalBMC Public Health
Publication statusPublished - 6 Dec 2012


  • Nicotine vaccination
  • NicVAX
  • Varenicline
  • Combination therapy
  • Efficacy
  • Safety
  • Immunogenicity
  • Randomized controlled trial

Cite this